ReviewCureus2025

Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review.

Bryan Tassavor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.